References
Kwong KK, Chan S (2014) Intranasal oxytocin and NSAIDs. Comment on: oxytocin nasal spray in fibromyalgic patients. Rheumatol Int [Epub ahead of print]
Mameli S, Pisanu G, Sardo S, Marchi A, Pili A, Carboni M, Minerba L, Trincas G, Carta MG, Melis MR, Agabio R (2014) Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int 34:1047–1052
Agabio R, Mameli S, Sardo S, Minerba L, Melis MR (2014) Oxytocin nasal spray in fibromyalgic patients: additional information: reply to the comment to the editor entitled “Future directions for the investigation of intranasal oxytocin and pain”. Rheumatol Int 34:1335–1336
Anderberg UM, Uvnäs-Moberg K (2000) Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 59:373–379
Pamuk ON, Cakir N (2005) The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 23:778–782
Salonia A, Nappi RE, Pontillo M, Daverio R, Smeraldi A, Briganti A, Fabbri F, Zanni G, Rigatti P, Montorsi F (2005) Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm Behav 47:164–169
Gordon I, Martin C, Feldman R, Leckman JF (2011) Oxytocin and social motivation. Dev Cogn Neurosci 1:471–493
Yeomans DC, Angst M, Mechanic J, Jacobs D (2013) Therapeutic effect of nasal oxytocin in chronic migraine: dependence on cytokines. In: International Headache Congress 2013, Boston: Cephalalgia 33:58–59
Ohlsson B, Truedsson M, Bengtsson M, Torstenson R, Sjölund K, Björnsson ES, Simren M (2005) Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 17:697–704
Wang YL, Yuan Y, Yang J, Wang CH, Pan YJ, Lu L, Wu YQ, Wang DX, Lv LX, Li RR, Xue L, Wang XH, Bi JW, Liu XF, Qian YN, Deng ZK, Zhang ZJ, Zhai XH, Zhou XJ, Wang GL, Zhai JX, Liu WY (2013) The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides 47:93–97
Robinson ICAF (1985) Radioimmunoassay of oxytocin: the standard. In: oxytocin: clinical and laboratory studies. In: Amico JA, Robinson AG (eds) Excerpta Medica International Congress Series 666, 2nd edn. Elsevier Science Publishers, Amsterdam, pp 24–30
Knigge U, Kjaer A, Kristoffersen U, Madsen K, Toftegaard C, Jørgensen H, Warberg J (2003) Histamine and prostaglandin interaction in regulation of oxytocin and vasopressin secretion. J Neuroendocrinol 15:940–945
Pulkkinen MO (1979) Suppression of uterine activity by prostaglandin synthetase inhibitors. Acta Obstet Gynecol Scand Supp 87:39–43
Caldwell JD, Hruby VJ, Hill P, Prange AJ Jr, Pedersen CA (1986) Is oxytocin induced grooming mediated by uterine-like receptors? Neuropeptides 8:77–86
Caldwell JD, Walker CH, O’Rourke ST, Faggin BM, Morris M, Mason GA (1996) Analogies between oxytocin systems of the uterus and brain. Horm Metab Res 28:65–74
Argiolas A, Melis MR, Stancampiano R, Gessa GL (1990) Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins. Pharmacol Biochem Behav 35:601–605
Rash JA, Campbell TS (2014) Future directions for the investigation of intranasal oxytocin and pain: comment on: Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int 34:1177–1178
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agabio, R., Mameli, S. & Melis, M.R. The lack of efficacy of oxytocin and NSAIDs. Rheumatol Int 35, 943–944 (2015). https://doi.org/10.1007/s00296-014-3200-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3200-2